Reference : Le traitement biologique des maladies inflammatoires à médiation immune. Le cas de la...
Scientific journals : Article
Human health sciences : Rheumatology
http://hdl.handle.net/2268/72439
Le traitement biologique des maladies inflammatoires à médiation immune. Le cas de la dermatologie et de la rhumatologie
French
[en] Biological therapy of inflammatory diseases
Von Frenckell, Christian mailto [Université de Liège - ULg > > Rhumatologie >]
Henno, Audrey [Université de Liège - ULg > > Dermatologie >]
de LA BRASSINNE, Michel mailto [Université de Liège - ULg > > Dermatologie >]
Malaise, Michel mailto [Université de Liège - ULg > Département des sciences cliniques > Rhumatologie >]
2007
Revue Médicale de Liège
Hopital de Baviere
62
Spec No
55-62
Yes (verified by ORBi)
National
0370-629X
Liège
Belgique
[en] Tumor Necrosis Factor-alpha ; Inflammation
[en] The pathophysiology and the treatment of diseases with clinical presentation so
different as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis
and psoriasis vulgaris have been revolutionized by the discovery of common
pro-inflammatory effector mechanisms involving TNF-alpha and by the use of
targeted therapies, the anti-TNF-alpha antibodies. In the past 10 years, our
experience has helped several hundreds of patients who were treated with novel
drugs, years before they became routinely available. In parallel tools of
metrology were developped that can now be applied to the routine patient. Lastly,
clinical research on these new drugs has also generated derived research works
allowing the university hospital to satisfactorilly fullfil its specific
missions.
Researchers ; Professionals ; Students ; General public
http://hdl.handle.net/2268/72439
http://www.rmlg.ulg.ac.be

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Malaise_2007_RevMedLiege_SpecNo.pdfPublisher postprint746.18 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.